Loss of alternately spliced messenger RNA of the luteinizing hormone receptor and stability of the follicle-stimulating hormone receptor messenger RNA in granulosa cell tumors of the human ovary

Gynecologic Oncology

Volumn 79, Issue 2, 2000, Pages 264-271

  Reinholz, M M ^a   Zschunke, M A ^a   Roche, P C ^a  

^a MAYO CLINIC   (United States)

Author keywords

FSHR; Granulosa cell tumor; Isoform; LHR; mRNA; Ovary

Indexed keywords

DNA; FOLLITROPIN RECEPTOR; LUTEINIZING HORMONE RECEPTOR; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GRANULOSA CELL TUMOR; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; TUMOR VOLUME;

EID: 0033757034     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.5946     Document Type: Article

References (46)

1. Inhibin as a marker for granulosa cell tumours
2. A prospective study of inhibin in granulosa cell tumors of the ovary
3. Mullerian inhibiting substance as a marker for ovarian sex-cord tumor
4. Localization of gonadotropin binding sites in human ovarian neoplasms
5. Hormonal control of gene expression in the ovary
6. Effects of luteinizing hormone on phosphoinositide metabolism in rat granulosa cells
7. 2+ mobilization by the LH receptor expressed in Xenopus oocytes independent of 3',5'-cyclic adenosine monophosphate formation: Evidence for parallel activation of two signaling pathways
8. 2+ mobilization
9. Intracellular signaling in the gonads
10. The C-terminal third of the human luteinizing hormone (LH) receptor is important for inositol phosphate release: Analysis using chimeric human LH/follicle-stimulating hormone receptors
11. Dual signaling potential is common among G(s)-coupled receptors and dependent on receptor density
12. Structure of the lutropin/choriogonadotropin receptor
13. Molecular cloning of a truncated isoform of the human follicle stimulating hormone receptor
14. Genetic basis of endocrine disease: Mutations in G proteins and G protein-coupled receptors in endocrine disease
15. Activating and inactivating mutations in LH receptors
16. Clinical manifestations of genetic defects affecting gonadotropins and their receptors
17. Functional and clinical consequences of mutations in the FSH receptor
18. G protein-coupled receptor systems involved in cell growth and oncogenesis
19. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
20. Genetic alterations in thyroid hyperfunctioning adenomas
21. Activating mutations of the TSH receptor in differentiated thyroid carcinomas
22. Structural studies of the thyrotropin receptor and Gsα in human thyroid cancers: Low prevalence of mutations predicts infrequent involvement in malignant transformation
23. Ovarian stimulation and granulosa-cell tumour
24. Ovarian stimulation and granulosa-cell tumor
25. Ovarian stimulation and granulosa-cell tumour
26. A mutation in the follicle-stimulating hormone receptor occurs frequently in human sex cord tumors
27. No evidence of a role for mutations or polymorphisms of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors
28. Alternative splicing in the control of gene expression
29. RNA splice junctions of different classes of eukaryotes: Sequence statistics and functional implications in gene expression
30. Expression of the LH/CG receptor gene in rat ovarian tissue is regulated by an extensive alternative splicing of the primary transcript
31. Cloning of rat lutropin (LH) receptor analogs lacking the soybean lectin domain
32. Expression of luteinizing hormone/human chorionic gonadotrophin (LH/HCG) receptor mRNA in the human ovary
33. Characterization and relative abundance of alternately spliced luteinizing hormone receptor messenger ribonucleic acid in the ovine ovary
34. Cloning and sequencing of porcine LH-hCG receptor cDNA: Variants lacking transmembrane domain
35. Variant forms of the pig lutropin/choriogonadotropin receptor
36. Characterization of different sizes of rat luteinizing hormone/chorionic gonadotropin receptor messenger ribonucleic acids
37. Endocrine tumors of the ovary
38. Ovarian tumors in a cohort of infertile women
39. Breast and ovarian cancer incidence after infertility and in vitro fertilization
40. Ovarian cancer: A risk of infertlity treatment?
41. α-Inhibin is a tumour-suppressor gene with gonadal specificity in mice
42. Structure and regulation of the luteinizing hormone receptor gene
43. Mutational analyses of the extracellular domain of the full-length lutropin/choriogonadotropin receptor suggest leucine-rich repeats 1- 6 are involved in hormone binding
44. Cloning and sequencing of human LH/hCG receptor cDNA
45. Isolation of TSH and LH/CG receptor cDNAs from human thyroid: Regulation by tissue specific splicing
46. No evidence for oncogenic mutations in the adrenocorticotropin receptor gene in human adrenocortical neoplasms